NEW YORK – Sequencing technology company Armonica Technologies said on Monday that it has closed a $2 million Series B financing round.
Hamamatsu Photonics joined as a new investor, as did previous investors Cottonwood Technology Fund, Sun Mountain Capital, and Tramway Venture Partners.
In a statement, Armonica said the funding will be used to support further feasibility demonstrations of its sequencing technology.
Based in Albuquerque, New Mexico, Armonica is developing a solid-state nanopore sequencing device that uses Raman spectroscopy for detection. In April, the firm announced that it identified spectral fingerprints for the four natural DNA bases as well as nine epigenetically modified bases.
In March, the firm announced that it had received a $349,200 Small Business Innovation Research grant from the National Human Genome Research Institute to optimize its nanostructures for single-base sensitivity and spatial resolution.